Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating biomarkers during progression to type 1 diabetes: A systematic review. | Front Endocrinol (Lausanne) | 2023 | 36817583 | PubTator, text mining | PubMed |
| LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer. | Front Immunol | 2023 | 36817434 | PubTator, text mining | PubMed |
| Quantitative trait loci on chromosomes 9 and 19 modulate AII amacrine cell number in the mouse retina. | Front Neurosci | 2023 | 36816119 | PubTator, text mining | PubMed |
| Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment. | Front Immunol | 2023 | 36814908 | PubTator, text mining | PubMed |
| Mathematical model of mechanobiology of acute and repeated synaptic injury and systemic biomarker kinetics. | Front Cell Neurosci | 2023 | 36814869 | PubTator, text mining | PubMed |
| Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study. | MedComm (2020) | 2023 | 36814688 | PubTator, text mining | PubMed |
| Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target. | Clin Transl Med | 2023 | 36808888 | PubTator, text mining | PubMed |
| Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens. | BMC Cancer | 2023 | 36803573 | PubTator, text mining | PubMed |
| A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer. | J Adv Res | 2023 | 36791960 | PubTator, text mining | PubMed |
| The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma. | Cureus | 2023 | 36788860 | PubTator, text mining | PubMed |
| Leucine-rich repeats containing 4 protein (LRRC4) in memory, psychoneurosis, and glioblastoma. | Chin Med J (Engl) | 2023 | 36780420 | PubTator, text mining | PubMed |
| Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma. | Cancer Res | 2023 | 36779841 | PubTator, text mining | PubMed |
| Extracellular vesicles, the emerging mirrors of brain physiopathology. | Int J Biol Sci | 2023 | 36778117 | PubTator, text mining | PubMed |
| The Genome Regions Associated with Abiotic and Biotic Stress Tolerance, as Well as Other Important Breeding Traits in Triticale. | Plants (Basel) | 2023 | 36771703 | PubTator, text mining | PubMed |
| Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges. | J Clin Med | 2023 | 36769602 | PubTator, text mining | PubMed |
| Application of Single-Cell and Spatial Omics in Musculoskeletal Disorder Research. | Int J Mol Sci | 2023 | 36768592 | PubTator, text mining | PubMed |
| SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients. | Int J Mol Sci | 2023 | 36768220 | PubTator, text mining | PubMed |
| Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data. | Cells | 2023 | 36766710 | PubTator, text mining | PubMed |
| An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies. | Cancer Inform | 2023 | 36762284 | PubTator, text mining | PubMed |
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report. | Clin Cancer Res | 2023 | 36749880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=21